Old Web
English
Sign In
Acemap
>
Paper
>
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.
Lasting response after discontinuation of cemiplimab in a patient with locally advanced basal cell carcinoma.
2021
V. De Giorgi
Luciana Trane
I. Savarese
Flavia Silvestri
Federico Venturi
Biancamaria Zuccaro
Federica Scarfì
Keywords:
Discontinuation
locally advanced
Cancer research
Monoclonal antibody
Skin cancer
Medicine
Basal cell carcinoma
immune checkpoint inhibitors
Correction
Source
Cite
Save
Machine Reading By IdeaReader
5
References
1
Citations
NaN
KQI
[]